市場調查報告書

全球人造器官·生物工學市場:成長,趨勢,及預測

Artificial Organs and Bionics Market - Growth, Trends and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 925208
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
全球人造器官·生物工學市場:成長,趨勢,及預測 Artificial Organs and Bionics Market - Growth, Trends and Forecasts (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

本報告提供全球人造器官·生物工學市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,類型·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 殘疾和器官衰竭的發生率增加
    • 交通事故高發導致截肢
    • 供體器官不足
    • 人造器官和仿生學的技術進步
  • 市場阻礙因素
    • 手術的高成本
    • 兼容性問題和故障風險
  • 波特的五力分析

第5章 市場區隔

  • 各類型
    • 人造器官
    • 生物工學
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abiomed Inc
    • 旭化成醫學株式會社
    • Baxter International, Inc.
    • Berlin Heart GmbH
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • Esko Bionics
    • Ossur
    • Getinge AB
    • Medtronic Inc.

第7章 市場機會及今後趨勢

目錄
Product Code: 50463

The major factors that are responsible for the growth of the artificial organs and bionics market includes the increasing incidence of disabilities and organ failures, technological advancements, and high incidence of road accidents leading to amputations.

Another primary factor is the scarcity of donor organs. The lack of availability of potential organs to transplant has been a major issue. The demand for organ donors is ever increasing, and is very high compared to the actual supply. According to a 2019 report by University of Pennsylvania there are more than 120,000 people awaiting transplantation in the United States. This has been a major boost for the artificial organ bionics market, as the patients cannot afford to wait in queue since the stakes are very high. Bionics and artificial organs are able to cater to the needs of those in need of organ transplantations and replacements. They can replicate the function of damaged organs.

However, the factors, such as the fear of device malfunction, risk of compatibility of artificial organs and their consequences, among others, may impact the market growth. These implants are also expensive, which has also been a restraining factor for the market growth.

Key Market Trends

Kidney Implants are Expected to to Cover a Large Share of the Market

According to a 2019 report by Centers for Disease Control and Diagnostics, Diabetes is one of the most common causes of chronic kidney disease (CKD) and the primary cause of kidney failure. The data from the report indicates that the percentage of adults with diagnosed diabetes estimated to have advanced stage CKD (stage 3 or 4) increased from 19.5% in 1999-2004 to 24.5% in 2011-2014. Moreover, the prevalence of diabetes is increasing.

Hemodialysis is a method for removing waste products such as creatinine and urea, as well as free water from the blood when the kidneys are in kidney failure. The artificial kidney is used to clean the patient's blood. Hence, the other name for artificial kidney is also called a dialysis machine.

Dialysis is an important function of the body, which involves filtration and excretion of metabolic waste products, regulation of necessary electrolytes and fluids and stimulation of red blood cell-production. Hence, as the prevalence of kidney failure increases, the demand for artificial kidney is also expected to increase.

North America is Expected to Dominate the Artificial Organs and Bionics Market

Currently, North America dominates the market for artificial organs and bionics, and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. The rising prevalence of chronic diseases and increasing demand for non-invasive surgical procedures are helping in the dominance of the North American region in artificial organs and bionics market. The presence of developed healthcare infrastructure is also expected to propel the market.

Competitive Landscape

Majority of the artificial organs and bionics are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Incidence of Disabilities and Organ Failures
    • 4.2.2 High Incidence of Road Accidents Leading to Amputations
    • 4.2.3 Scarcity of Donor Organs
    • 4.2.4 Technological Advancements in the Artificial Organ and Bionics
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures
    • 4.3.2 Risk of Compatibility Issues and Malfunctions
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Artificial Organ
      • 5.1.1.1 Artificial Heart
      • 5.1.1.2 Artificial Kidney
      • 5.1.1.3 Artificial Lungs
      • 5.1.1.4 Cochlear Implants
      • 5.1.1.5 Other Organ Types
    • 5.1.2 Bionics
      • 5.1.2.1 Vision Bionics
      • 5.1.2.2 Ear Bionics
      • 5.1.2.3 Orthopedic Bionic
      • 5.1.2.4 Cardiac Bionics
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abiomed Inc
    • 6.1.2 Asahi Kasei Medical Co., Ltd
    • 6.1.3 Baxter International, Inc.
    • 6.1.4 Berlin Heart GmbH
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 Cyberonics Inc.
    • 6.1.7 Esko Bionics
    • 6.1.8 Ossur
    • 6.1.9 Getinge AB
    • 6.1.10 Medtronic Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS